严重的异常分泌性腹与对索马托斯坦类同类药物的深度持续反应:一个病例报告
Geovanny Gandy1,2, Alexander James Anthony Prudence2,3, Miriam Tania Levy1,2
1Gastroenterology Department, Liverpool Hospital, Liverpool, New South Wales, Australia.
Case reports in gastrointestinal medicine
|November 6, 2025
概括
本案例研究显示,患有慢性分泌性腹的患者,疑似由VIPoma引起,对索马托斯坦类同类药物反应良好. 这表明这些药物可能有助于当原因未知时的异常分泌性腹.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 慢性分泌性腹带来了诊断上的挑战.
- 必须考虑更罕见的原因,如VIPomas.
- 血管活性肠道 (VIP) 分泌的神经内分泌瘤 (VIPomas) 导致患者显著的发病率.
研究的目的:
- 提出一个慢性分泌性腹病例,怀疑是VIPoma.
- 探索索马托斯塔丁类似物在治疗耐火分泌性腹中的作用.
- 突出诊断困境在识别腹的罕见原因.
主要方法:
- 一个35岁的女性的详细病例介绍,她有两年的严重腹病史.
- 包括生物化学,内镜和放射学研究在内的广泛调查.
- 使用索马托斯塔丁类似物 (奥克特雷奥提德和兰雷奥提德) 的治疗试验.
主要成果:
- 尽管进行了广泛的检查,但没有发现VIPoma,血清VIP水平正常.
- 经验性治疗带来了快速症状的解决.
- 长期使用兰类药物治疗导致完全缓解,停药后复发,重新开始后恢复.
结论:
- 索马托斯坦类类似物可能有效治疗异常分泌性腹.
- 在耐火病例中,应考虑对索马托他类型的治疗试验.
- 这一案例表明,索马托斯塔丁类药物在经证实的神经内分泌瘤之外发挥了更广泛的作用.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
612
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
612
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
722
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
722
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
622
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
622
Chronic Pancreatitis II: Collaborative Care
303
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
303
Drugs for Treatment of Constipation-Predominant IBS
686
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
686
Inflammatory Bowel Disease V: Surgical Management
430
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
430


